Zhong Lun assisted Medprin on the deal.Guangzhou Maipu Regenerative Medicine Technology Co., Ltd. executed an initial public offering and went public on ChiNext of the Shenzhen Stock…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
